MAKENZE WIENEKE: Open Payments
NPI 1649014416 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 11 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $63 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $34 |
| Dexcom, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $7 |
Products named: Dexcom G6 Transmitter, Ozempic, CAPLYTA, Cologuard Collection Kit, Kerendia, KISUNLA, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
